Auranofin has entered Phase I/II clinical trials for patients with chronic lymphocytic leukemia (NCT01419691), ovarian cancer (NCT01747798), and lung cancer (NCT01737502), which are still ongoing
However, it should be noted that the reductions were more pronounced in male rats than in female rats (Vallof et al., 2020), suggesting that sex differences in treatment outcome should be further evaluated in upcoming studies
There was a significant increase in the serum ALB concentration in the L-carnitine group ( P = 0.036) after the intervention [43]
Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction
Because the number of hydrogen or hydroxyl ions is not limited to 10^7, pH below 0 or above 14 is possible
Discussing your kidney health with your doctor prior to starting this medication could be beneficial